ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01937117
Brief Title: Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

First Submitted : September 3, 2013
First Submitted that Met QC Criteria : September 3, 2013
First Posted : September 9, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : August 13, 2018
Last Update Posted : August 14, 2018